Pre-exposure prophylaxis (PrEP) adherence continues to be one of the main challenges for the elimination of HIV transmission. Researchers tested the use of an automated directly observed therapy...
In a recent study, researchers examined the effectiveness of text messaging to support the use of pre-exposure prophylaxis use in certain patient populations who are at high-risk of HIV infection.
Researchers aimed to determine the risk profile of individuals without HIV who were seeking vaccination against mpox and if these patients would benefit from HIV pre-exposure prophylaxis use.
Researchers determined the predictive value of urine point-of-care tenofovir antibody test and compared the results against self-reported PrEP use and TFV-diphosphate levels in dried blood spots. Their...
Researchers compared pre-exposure prophylaxis (PrEP) use with birth outcomes using objective levels of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) of women during the second or third trimester...
Researchers examined the efficacy of post-exposure prophylaxis for the prevention of sexually transmitted infections among certain patient populations living with HIV or on HIV pre-exposure prophylaxis. ...
The Department of Health and Human Services recommends testing for sexually transmitted infections prior to beginning PrEP for those at-risk of HIV. Researchers examined the prevalence of these infections...
In a recent study, researchers examined the rates of screening and various outcomes associated with PrEP use for HIV within emergency department settings.
Researchers conducted a systematic review and meta-analysis of data among men who have sex with men to investigate the awareness of pre-exposure prophylaxis (PrEP) and willingness to use PrEP.
